DG vs DMAC · P/E 15, rev $40.61B vs $157.4M cap
Dollar General Corporation (DG) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported DG revenue for 2025-01-31 was $40.61B. Net income was $1.13B. Revenue was up 5.0% from 2024-02-02 to 2025-01-31. DG currently screens at market cap $22.87B and trailing P/E 14.7.
DMAC does not have a complete income-statement cache yet.
DG currently screens at market cap $22.87B and trailing P/E 14.7. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the DG and DMAC stock pages for the full models.
Not investment advice.